PSTAX
Price
$22.06
Change
-$0.04 (-0.18%)
Updated
Sep 20 closing price
RGEBX
Price
$73.82
Change
-$0.14 (-0.19%)
Updated
Sep 20 closing price
Ad is loading...

PSTAX vs RGEBX

Header iconPSTAX vs RGEBX Comparison
Open Charts PSTAX vs RGEBXBanner chart's image
Virtus KAR Capital Growth A
Price$22.06
Change-$0.04 (-0.18%)
VolumeN/A
CapitalizationN/A
American Funds Growth Fund of Amer R2E
Price$73.82
Change-$0.14 (-0.19%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
PSTAX vs RGEBX Comparison Chart
Loading...
VS
PSTAX vs. RGEBX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PSTAX is a StrongBuy and RGEBX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 290B vs. PSTAX (658M). RGEBX pays higher dividends than PSTAX: RGEBX (0.16) vs PSTAX (0.00). PSTAX was incepted earlier than RGEBX: PSTAX (29 years) vs RGEBX (10 years). RGEBX is a more actively managed with annual turnover of: 31.00 vs. PSTAX (12.00). RGEBX has a lower initial minimum investment than PSTAX: RGEBX (250) vs PSTAX (2500). PSTAX (23.68) and RGEBX (22.86) have marching annual gain over last year. RGEBX return over 5 years is better than : 47.60 vs. PSTAX (27.82).
PSTAXRGEBXPSTAX / RGEBX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence29 years10 years-
Gain YTD20.25518.896107%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets658M290B0%
Annual Yield % from dividends0.000.16-
Returns for 1 year23.6822.86104%
Returns for 3 years-27.40-4.80571%
Returns for 5 years27.8247.6058%
Returns for 10 years61.6856.25110%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HLNE158.621.25
+0.79%
Hamilton Lane
IE7.390.03
+0.41%
Ivanhoe Electric
HLN10.55-0.10
-0.94%
Haleon plc
COMM5.60-0.08
-1.41%
CommScope Holding Company
QNCX0.74-0.02
-2.65%
Quince Therapeutics